As changes to various parts of the current healthcare model are considered, we are actively engaged with policy leaders, pharmaceutical manufacturers, healthcare providers and other stakeholders to ensure that changes do not negatively affect patient access to the best care possible and that our role in the supply chain continues to be understood and recognized.